Design and rationale of the EMPagliflozin after Aortic Valve Replacement (EMPAVR) study: A randomized clinical trial. - Sørensen LM; Reinert MS; Raja AA; de Backer O; Bieliauskas G; Schou M; Jensen J; Møller ELR; Linde JJ; Kofoed KF; Kühl JT; Procida K; et al. (American heart journal, 2026)